Prognosis of Chronic Heart Failure and Gout

Links shared publicly online about this topic

Cardiology Article | Heart Failure

mdlinx.com — “Excess Ventilation During Exercise and Prognosis in Chronic Heart FailureView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on January 27, 2011 at 9:09 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Excess Ventilation During Exercise and Prognosis in Chronic Heart Failure: American Journal of Respi... http://bit.ly/hp6LG1 #cardiology

1 year ago...

Cardiology Medical News about Heart Failure

mdlinx.com — “Impact of Longitudinal Myocardial Deformation on the Prognosis of Chronic Heart Failure PatientsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 31, 2010 at 2:46 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Impact of Longitudinal Myocardial Deformation on the Prognosis of Chronic Heart Failure Patients: C... http://bit.ly/bRcpMo #cardio #mdlinx

2 years ago...

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients

news-medical.net — “The novel cardiac biomarker ST2 was highlighted in a presentation at last month's 2011 Heart Failure Congress of the European Society of Cardiology in Gothenburg, Sweden. As this study and others have demonstrated, a patient's ST2 level can help a physician better predict prognosis in ambulatory, chronic heart failure patients, which can allow physicians to more appropriately tailor care.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 10, 2011 at 12:38 pm By:

SpecialtyWisdom OrganizedWisdom OW Health

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients: The novel cardiac biomarker ST2... http://bit.ly/mwBSke

12 months ago...

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients

news-medical.net — “The novel cardiac biomarker ST2 was highlighted in a presentation at last month's 2011 Heart Failure Congress of the European Society of Cardiology in Gothenburg, Sweden. As this study and others have demonstrated, a patient's ST2 level can help a physician better predict prognosis in ambulatory, chronic heart failure patients, which can allow physicians to more appropriately tailor care.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 10, 2011 at 9:02 am By:

NewsMedical News-Medical.Net Health News

ST2 biomarker can help indicate prognosis in ambulatory cardiovascular patients: The novel cardiac biomarker ST2... http://bit.ly/jy5dX8

12 months ago...

ESC> About the ESC> ESC Press Office> ESC Press Releases> 2009 General Press Releases> Recognising the signs and symptoms of acute heart failure - Instruction will help minimise treatment delay and reduce complications

escardio.org — “ESC> About the ESC> ESC Press Office> ESC Press Releases> 2009 General Press Releases> Recognising the signs and symptoms of acute heart failure - Instruction will help minimise treatment delay and reduce complicationsView full resource at escardio.org

  • View Related
  • Share

Most Recently Shared on May 31, 2009 at 2:32 pm By:

escardio European Cardiology Cardiology and Medical Society

Press Rel.: Recognising signs & symptoms of acute heart failure http://tinyurl.com/lkqvzw

3 years ago...

FDA Clears Critical Diagnostics Presage ST2 Assay for Patients with Heart Failure | Biomarker Commons

biomarkercommons.org — “Critical Diagnostics is a U.S.-based biomarker company focused on optimizing patient care in cardiovascular diseases, such as heart failure.View full resource at biomarkercommons.org

  • View Related
  • Share

Most Recently Shared on December 16, 2011 at 2:20 pm By:

Cardiac Cirrhosis: eMedicine Cardiology

emedicine.medscape.com — “Overview: Cardiac cirrhosis (congestive hepatopathy) includes a spectrum of hepatic derangements that occur in the setting of right-sided heart failure. Clinically, the signs and symptoms of congestive heart failure (CHF) dominate the disorder. Unlike cirrhosis caused by ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 6:55 pm By:

Health_SS Susan S Health Advocate

Cardiac cirrhosis may describe a number of issues involved in right-side heart failure. Info about cardiac cirrhosis. http://bit.ly/bDfrm5

2 years ago...

Benefits Of Taking Part In Clinical Trials

medicalnewstoday.com — “Patients with chronic heart failure who agree to take part in clinical trials have a better prognosis than those who do not, according to a study reported in the november european journal of heView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on November 2, 2009 at 11:09 am By:

mnt_cardiovasc MNT Cardiovascular Health News

Benefits Of Taking Part In Clinical Trials: Patients with chronic heart failure who agree to take part in clini.. http://bit.ly/22H5wB

3 years ago...

BG Medicine Announces Nationwide Availability of Galectin-3 Testing Service through LabCorp | IVD Technology

ivdtechnology.com — “BG Medicine announced that Laboratory Corporation of America Holdings (LabCorp) is offering galectin-3 testing services using the BGM Galectin-3 test for heart failure. The BGM Galectin-3 test was cleared by FDA in November 2010 as an aid in assessing the prognosis of patients with chronic heart failure.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on January 18, 2011 at 7:44 pm By:

ivdtechnology IVD Technology Health Magazine

BG Medicine Announces Nationwide Availability of Galectin-3 Testing Service through LabCorp http://tinyurl.com/4mzxdof

1 year ago...

Health Diagnostic Laboratory Announces Availability of Galectin-3 Testing Service | IVD Technology

ivdtechnology.com — “Health Diagnostic Laboratory Inc. (HDL Inc.) and BG Medicine Inc. announced an agreement under which HDL Inc. will offer galectin-3 testing services based on the BG Medicine Galectin-3 Test. The BG Medicine Galectin-3 Test was recently cleared by FDA as an aid in assessing the prognosis of patients with chronic heart failure. The collaboration between BG Medicine and HDL Inc.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on March 24, 2011 at 7:11 pm By:

ivdtechnology IVD Technology Health Magazine

Health Diagnostic Laboratory Announces Availability of Galectin-3 Testing Service http://tinyurl.com/64o5kje

1 year ago...

Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine imaging in patients with ST-segment elevation myocardial infarction -- Kasama et al. 97 (1): 20 -- Heart

heart.bmj.com — “Kasama, Shu; Toyama, Takuji; Sumino, Hiroyuki; Kumakura, Hisao; Takayama, Yoshiaki; Minami, Kazutomo; Ichikawa, Shuichi; Matsumoto, Naoya; Sato, Yuichi; Kurabayashi, MasahikoView full resource at heart.bmj.com

  • View Related
  • Share

Most Recently Shared on December 10, 2010 at 11:08 am By:

Heart_BMJ Heart_BMJ Medical Journal

Editor's Choice: Prognostic value of cardiac sympathetic nerve activity evaluated by [123I]m-iodobenzylguanidine... http://bit.ly/eLr4qy

1 year ago...

Right Ventricular Dysfunction is Associated With CKD - QualityPoint Technologies

qualitypointtech.net — “Chronic kidney disease and right ventricular dysfunction are important predictors of prognosis in heart failure. Find out more about this close relationship - in outpatients. European Journal of Heart FailureView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 12:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Right Ventricular Dysfunction is Associated With CKD: Chronic kidney disease and right ventricular dysfunction are... http://t.co/AR3UVNqG

2 months ago...

FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disease

news-medical.net — “BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 24, 2010 at 8:42 am By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA clears BG Medicine's Galectin-3 test to identify high risk patients with cardiovascular disea... http://twurl.nl/o6ln03

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • SpecialtyWisdom

    OrganizedWisdom

    Wisdom from medical professionals in top medical specialities who use Twitter to share health info, links, resources, and research to help people.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390